Pascal Soriot
Low Continental Public Record
Editorial estimate, not verified fact — DisclaimerChief Executive Officer, AstraZeneca
London, United Kingdom
Data Confidence: 75% · Sources: 2 · Last Updated: Sep 18, 2026
- Net Worth ▲
- Undisclosed — estimated significant wealth
- Reach ▲
- 200.0M people
- Power ▲
- Controls R&D and commercial strategy for one of the world's largest pharmaceutical companies, with medicines reaching patients in over 125 countries.
- Influence ▲
- AstraZeneca's drug pricing, trial results, and supply decisions directly affect healthcare systems and patient access worldwide.
- Network ▲
- Maintains direct relationships with global health regulators (FDA, EMA, MHRA) and biotech partners across AstraZeneca's pipeline.
- Legacy ▲
- Longest-serving major pharma CEO of his cohort, credited with AstraZeneca's oncology-led turnaround since 2012 and its COVID-19 vaccine program.
- Trajectory ▬
- Stable — first assessment on record.
About
Pascal Soriot has served as CEO of AstraZeneca, the British-Swedish pharmaceutical multinational, since 2012. Under his leadership the company has pursued an 'Ambition 2030' growth strategy with more than 100 Phase III clinical trials underway as of 2026.
Known For
Leading AstraZeneca, one of the world's largest pharmaceutical companies, for over a decade including through the COVID-19 vaccine rollout.
Connections
Leadership & Employment
Similar Profiles
Meg O'NeillLow ContinentalChief Executive Officer, BP
Wael SawanLow ContinentalChief Executive Officer, Shell
Andrew BaileyLow ContinentalGovernor of the Bank of England
General MotorsTop ContinentalMultinational automotive manufacturing corporation
Bharatiya Janata PartyTop ContinentalRuling political party of India and world's largest political party by membershipSources
- Wikipedia: Pascal Soriotcorroborated
- Semafor: AstraZeneca CEO interviewcorroborated